Home › NDC Lookup › RxCUI directory › RxCUI 2203993

Sofosbuvir 150 MG Oral Pellet — RxCUI 2203993

RxNorm drug concept · Semantic clinical drug
RxCUI 2203993 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2203993
Official nameSofosbuvir 150 MG Oral Pellet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assofosbuvir 150 MG per packet Oral Pellets
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sofosbuvir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sovaldi works by blocking a specific enzyme the hepatitis C virus needs to copy itself. When used correctly as part of a combination treatment, many people do clear the virus compl...
  • What exactly does Sovaldi do — is it a cure for hepatitis C?
  • You can take Sovaldi with or without food — it doesn't matter. Studies showed that even a high-fat meal doesn't significantly change how much medicine gets into your system. Just t...
  • Can I take Sovaldi with food, or does it need to be on an empty stomach?
📖 Read our full Sofosbuvir guide →

🕸️ Concept Web — How Sofosbuvir 150 MG Oral Pellet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sofosbuvir 150 MG Oral Pellet RxCUI 2203993

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sofosbuvir 1484911
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sovaldi 1484917
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sofosbuvir Oral Pellet 2203992
    • Sofosbuvir Oral Product 1484913
    • Sofosbuvir Pellet Product 2203991
    • Sofosbuvir Oral Pellet [Sovaldi] 2277903
    • Sovaldi Oral Product 1486581
    • Sovaldi Pellet Product 2277904
    • Oral Pellet 317691
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sofosbuvir 150 MG SCDC · 2203990
  • Sofosbuvir Oral Pellet SCDF · 2203992
  • Sofosbuvir Oral Product SCDG · 1484913
  • Sofosbuvir Pellet Product SCDG · 2203991

Brand-Name Concepts

  • Sofosbuvir 150 MG Oral Pellet [Sovaldi] SBD · 2203999
  • Sofosbuvir 150 MG [Sovaldi] SBDC · 2277902
  • Sofosbuvir Oral Pellet [Sovaldi] SBDF · 2277903
  • Sovaldi Oral Product SBDG · 1486581
  • Sovaldi Pellet Product SBDG · 2277904
  • Sovaldi BN · 1484917

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2203993 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61958-1501-01 28 TABLET, FILM COATED in 1 BOTTLE (61958-1501-1) Sovaldi Gilead Sciences, Inc. 2013-12-06
61958-1503-01 28 TABLET, FILM COATED in 1 BOTTLE (61958-1503-1) Sovaldi Gilead Sciences, Inc. 2019-08-28
61958-1504-01 60 PELLET in 1 PACKET (61958-1504-1) Sovaldi Gilead Sciences, Inc. 2019-08-28
61958-1505-01 80 PELLET in 1 PACKET (61958-1505-1) Sovaldi Gilead Sciences, Inc. 2019-08-28
Observed labelers: Gilead Sciences, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.